Cell Culture Market Size to grow by USD 24.8 billion between 2024-2028
According to a research report “ Cell Culture Market” by Product (Consumables, Equipment) End-user (Pharma and biotech companies, Hospitals, Research and academic Institutes, Others) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 24.8 billion, at a CAGR of almost 13.64% during the forecast period. The global population growth and increased prevalence of infectious diseases, such as Ebola, SARS, swine flu, Zika, Lassa fever, and most recently, COVID-19, pose significant challenges to public health. These diseases spread rapidly, often within a week, and can be highly contagious, transmitting through cough and sneeze droplets of infected individuals. For instance, SARS and COVID-19, caused by coronaviruses, are severe respiratory illnesses that have become global pandemics. In 2020, a large portion of the world's population was impacted by COVID-19, highlighting the urgent need for effective containment measures and advanced medical solutions. Cell culture technology plays a crucial role in the research, development, and production of vaccines and therapeutics to combat these infectious diseases, making it a vital market sector for businesses.
Browse market data tables, figures, and in-depth TOC on “Cell Culture Market” by Product (Consumables, Equipment) End-user (Pharma and biotech companies, Hospitals, Research and academic Institutes, Others) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Product, the Consumables segment is projected to dominate the market size in 2024
Cell culture plays a pivotal role in the biotechnology industry, enabling investigations into the biology, biochemistry, and physiology of both healthy and diseased cells. Pharmaceutical and biotech companies heavily rely on this technology for drug development and testing, vaccine production, tissue regeneration and transplantation, and genetic engineering and gene therapy. With the ongoing advancements in biomedicine, the demand for new vaccines and medicines is escalating. Consequently, the research and development sector in biotechnology is expanding, leading to an increased requirement for cell culture technology.
By End-user, Pharma and biotech companies segment is expected to hold the largest market size for the year 2024
In the dynamic and expansive cell culture market, consumables hold a significant position, accounting for the largest revenue share. These consumables encompass essential items such as sera, media, and reagents. Sera include adult bovine sera (ABS), fetal bovine sera (FBS), and other animal sera. Media offerings span serum-free media, stem cell media, specialty media, and classical media and salts. Reagents comprise supplements, growth factors, cell dissociation reagents, contamination detection kits, antibiotics, antimycotics, cell culture reagents, salt solutions, buffers, and other accessories. The high availability and broad applicability of consumables, coupled with their frequent usage, contribute to their substantial market presence. Moreover, the affordability of consumables, which are often sold alongside compatible instruments at reduced prices compared to separate purchases, further bolsters their widespread adoption.
North America is forecasted to hold the largest market size by region in 2024
The cell culture market is experiencing significant growth due to the increasing demand for advanced research and development in various industries, including pharmaceuticals, biotechnology, and food and beverage. This trend is driven by the benefits of cell culture techniques, such as cost-effectiveness, time efficiency, and ethical considerations. Key players in this market are investing in innovation and expansion to meet the growing demand for high-quality cell culture solutions.
The Cell Culture Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Cell Culture Market is witnessing significant growth due to the increasing demand for novel therapeutics in the Biotechnology, Pharmaceutical, and Biopharmaceutical industries. Companies like Captivate Bio are at the forefront of this trend, providing advanced cell culture tools and bioreactors for high-throughput screening of cells for drug discovery and development. Organoids, 3D cell cultures derived from stem cells, are revolutionizing cell biology research, particularly in the areas of Cardiovascular disorders, Neurological disorders, and Autoimmune disorders. Biotech firms are investing in single-use technologies to reduce contamination risks and improve efficiency. Collaborations between academia and industry are driving innovation, such as the recent partnership between CellVovant and the University of Bristol to develop novel cell therapies for Cardiovascular ailments. Seed funding is also fueling the growth of startups in this field, with CellVovant securing USD11 million in series A funding. The Cell Culture Market is expected to expand further as the demand for testing kits and viral vaccines increases. The Biotechnology industry is embracing cell culture as a key component of chronic disease research and the development of new therapeutics. The future of cell culture lies in the integration of advanced technologies and the continued exploration of cell biology.
Market Research Overview
The Cell Culture Market is experiencing significant growth due to the increasing demand for biotechnology and pharmaceutical applications. Mergers and acquisitions, such as Merck's acquisition of Sigma-Aldrich, have expanded the market by integrating diagnostics segment and cell culture media into one company. The Consumables segment, including functional tissues, artificial organs, and bioreactors, is also seeing growth in areas like high-throughput screening, organoids, and cell culture tools. Biotechnology and pharmaceutical companies are investing heavily in biopharmaceutical development, including viral vaccines, therapeutic proteins, monoclonal antibodies, and drug screening. Tissue engineering and diagnostics are also driving the market, with regulatory requirements and healthcare markets in emerging countries fueling demand. Single-use bioprocessing and plastic waste reduction are key trends, with capital investments in process development time and cost reduction. Collaborations between biotech companies, universities, and seed funding organizations, such as Captivate Bio and the University of Bristol's CellVovant, are also driving innovation in cell therapy for cardiovascular ailments, neurological disorders, autoimmune disorders, and cancer. Cell culture tools and testing kits are essential for drug research activities, with antibiotics and vaccines being major applications. The market is expected to continue growing, with novel therapeutics and single-use technologies leading the way in buying behavior.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
